EcoDrugPlus

Ttk Protein Kinase

Ensembl ID : ENSSARG00000002309
Gene Symbol: TTK
1 External references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSSARG00000003614
Gene Symbol: UGCG
1 External references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSSARG00000007814
Gene Symbol: WEE1
1 External references
226 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSSARG00000012410
Gene Symbol: YES1
1 External references
268 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSSARG00000009168
Gene Symbol: ACHE
1 External references
233 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSSARG00000003889
Gene Symbol: ACVRL1
1 External references
353 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSSARG00000014262
Gene Symbol: ADORA2A
1 External references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSSARG00000001156
Gene Symbol: ADORA2B
1 External references
200 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSSARG00000008092
Gene Symbol: ADRA1B
3 External references
263 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSSARG00000005581
Gene Symbol: ADRB2
1 External references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSSARG00000004970
Gene Symbol: ADRB3
1 External references
215 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSSARG00000009983
Gene Symbol: AGER
1 External references
169 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).